Xtant Medical Holdings, Inc.
XTNT
$0.612
-$0.008-1.29%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 127.77M | 122.30M | 117.27M | 113.86M | 110.94M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 127.77M | 122.30M | 117.27M | 113.86M | 110.94M |
| Cost of Revenue | 50.91M | 51.14M | 49.05M | 44.53M | 42.59M |
| Gross Profit | 76.86M | 71.16M | 68.22M | 69.33M | 68.36M |
| SG&A Expenses | 74.60M | 76.40M | 77.90M | 80.97M | 79.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 127.74M | 129.84M | 129.34M | 127.86M | 124.55M |
| Operating Income | 28.00K | -7.54M | -12.08M | -14.00M | -13.61M |
| Income Before Tax | -4.27M | -11.90M | -16.26M | -16.85M | -4.95M |
| Income Tax Expenses | 313.00K | 94.00K | 187.00K | 743.00K | -1.62M |
| Earnings from Continuing Operations | -4.58 | -11.99 | -16.45 | -17.59 | -3.33 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.58M | -11.99M | -16.45M | -17.59M | -3.33M |
| EBIT | 28.00K | -7.54M | -12.08M | -14.00M | -13.61M |
| EBITDA | 4.49M | -3.25M | -7.85M | -9.91M | -9.70M |
| EPS Basic | -0.03 | -0.09 | -0.12 | -0.13 | -0.02 |
| Normalized Basic EPS | -0.02 | -0.05 | -0.07 | -0.08 | -0.08 |
| EPS Diluted | -0.04 | -0.09 | -0.12 | -0.14 | -0.03 |
| Normalized Diluted EPS | -0.02 | -0.05 | -0.07 | -0.08 | -0.08 |
| Average Basic Shares Outstanding | 571.73M | 562.69M | 553.82M | 525.59M | 518.63M |
| Average Diluted Shares Outstanding | 585.26M | 566.96M | 553.82M | 525.59M | 526.16M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |